Stelac Advisory Services LLC Abbott Laboratories Transaction History

Stelac Advisory Services LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$114.02 - $139.04 $95,662 - $116,654	-839 Closed	0 $0
Q4 2021 Jun 28, 2022	BUY	$115.53 - $141.46 $96,929 - $118,684	839 New	839 $118,000
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $127,392 - $140,933	-1,092 Closed	0 $0
Q2 2021 Jun 28, 2022	SELL	$105.79 - $124.53 $18,619 - $21,917	-176 Reduced 13.88%	1,092 $127,000
Q2 2021 Aug 09, 2021	BUY	$105.79 - $124.53 $17,772 - $20,921	168 Added 15.27%	1,268 $147,000
Q1 2021 Jun 28, 2022	SELL	$108.84 - $128.23 $53,440 - $62,960	-491 Reduced 30.86%	1,100 $132,000
Q1 2021 May 13, 2021	BUY	$108.84 - $128.23 $4,027 - $4,744	37 Added 2.38%	1,591 $191,000
Q4 2020 Feb 11, 2021	BUY	$105.0 - $114.42 $33,075 - $36,042	315 Added 25.42%	1,554 $170,000
Q3 2020 Nov 02, 2020	BUY	$91.64 - $111.29 $113,541 - $137,888	1,239 New	1,239 $135,000
Q2 2019 Jul 29, 2019	SELL	$72.88 - $85.0 $133,370 - $155,550	-1,830 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$60.81 - $73.36 $111,282 - $134,248	1,830 New	1,830 $134,000

3,187

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Stelac Advisory Services LLC, based on Form 13F filings with the SEC.

Stay updated on Stelac Advisory Services LLC with notifications on news.